Contracts › 75N91023C00042
75N91023C00042: Arpa-H Sbir Phase Ii Topic Arpa-H 04 Intra-Operative Contrast Agents
Awarded to Trace Biosciences Inc by National Institutes of Health (NIH).
$4.2Mobligated
$4.2Mpotential value
14 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91023C00042 |
|---|---|
| Awardee | Trace Biosciences Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | OR |
| Offers received | 2 |
| Period of performance | 15 September 2023 to 14 September 2027 |
| Potential end | 14 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record